What happens to PSA on TRT?
PSA on TRT usually rises a little in the first year, then levels off. In the TRAVERSE trial, the largest so far, PSA rose about 0.15 ng/mL more on testosterone gel than on placebo at 12 months. The gap did not grow after that.
A small rise is expected. So guidelines compare each result with your own starting value instead of reading it alone. They also set clear points for a urology referral, covered below.
PSA is the one test on the full list of TRT labs that looks at the prostate.
What is PSA?
PSA (prostate-specific antigen) is a protein made by the prostate. The prostate is the walnut-sized gland below the bladder that wraps around the urethra. Most PSA ends up in semen.
A small amount leaks into the blood. A blood test measures it in nanograms per milliliter (ng/mL).
A higher PSA can come from prostate cancer. It can also come from an enlarged prostate, inflammation or infection. No PSA level proves cancer is present or absent.
That is why PSA is read as a trend and confirmed before anyone acts.
Why is PSA checked on testosterone therapy?
Testosterone acts on prostate tissue, and treatment is not given to men with known prostate cancer. Both major guidelines include a prostate check before starting. The Endocrine Society repeats it during the first year.
The Endocrine Society notes a side effect of monitoring itself. Treatment raises the chance of finding a small, hidden prostate cancer, because men are watched more closely and testosterone raises PSA. That can lead to more prostate biopsies.
When is PSA checked on TRT?
The two main guidelines differ a little:
- Endocrine Society: for men aged 55 to 69, and men aged 40 to 69 at higher risk, who choose prostate monitoring after talking it over with their clinician. It means PSA and a prostate exam before starting, again 3 to 12 months after starting, then in line with regular prostate cancer screening.
- AUA: PSA before starting in men over 40, and a second test if the first is raised. Later testing is a shared decision between you and your clinician.
The AUA gives a family history of prostate cancer and Black race as examples of higher risk. For men not on TRT, the US Preventive Services Task Force says PSA screening at 55 to 69 is a personal choice. It advises against routine screening from age 70.
Our blood-work timing guide shows where PSA fits next to the other tests. The draw-date planner can help you plan the dates.
What PSA results lead to a urology referral?
The Endocrine Society lists four reasons to send a man on testosterone to a urologist. A urologist is a doctor who treats the urinary tract and prostate. The guideline applies these in the first 12 months, and its monitoring table lists the PSA limit, prostate exam and urinary symptoms without a time limit.
| Trigger | What it means |
|---|---|
| Confirmed rise of more than 1.4 ng/mL above baseline | Compared with your own pre-treatment PSA |
| Confirmed PSA above 4.0 ng/mL | The absolute limit |
| An abnormal prostate exam | Found on a digital rectal exam |
| Substantially worse urinary symptoms | Such as a weak stream or getting up at night more |
“Confirmed” matters. The guideline asks clinicians to repeat a raised PSA first. This rules out a short-lived rise from prostatitis (an inflamed prostate) or normal test variation.
Before starting, the Endocrine Society advises against treatment without a urology review if PSA is above 4 ng/mL. For men at high risk, the cutoff is 3 ng/mL.
Two worked examples, for illustration only:
- Baseline 0.9, then 1.8 ng/mL at six months. That is a rise of 0.9, under 1.4, and the value is under 4.0. Neither PSA number trigger is met.
- Baseline 2.0, then 3.6 ng/mL at six months. That is a rise of 1.6, over 1.4, even though the value is still under 4.0. If a repeat test confirms it, the guideline points to a urology referral.
These are rules for prescribers. If a result is flagged high, call your prescriber and let them decide on a repeat test or referral. Do not change your treatment on your own.
What happens after a urology referral?
A referral is not a diagnosis. The urologist usually repeats the PSA, examines the prostate and talks through options. These may include watching the trend, imaging or a biopsy.
TRAVERSE shows how this plays out. Of the 5,204 men in its prostate analysis, 85 met the trial’s referral rules. Only 16 of the 85 chose a biopsy.
Of the 85, 60 had a PSA above 4.0 ng/mL, 37 had a rise of more than 1.4 ng/mL and 5 had a nodule. Some met more than one rule.
Prostate cancer was found in 23 men across the whole trial. Of these, 22 started with a PSA between 1 and 3 ng/mL. So a higher starting PSA, even within the normal range, is worth knowing about.
Is PSA velocity better than a single PSA number?
PSA velocity is how fast PSA rises over time. It sounds useful, and a fast climb does catch a prescriber’s eye. But a review of studies in untreated men found little proof that speed adds much beyond the PSA value itself.
That review did not study men on TRT. The Endocrine Society does not use a speed formula for men on TRT. It uses a fixed rise from your own baseline in the first year, plus an absolute limit.
The trend still matters. It just is not a separate test with its own cutoff.
How much does PSA rise on TRT?
Less than many people fear, and more in men who start higher. TRAVERSE looked at 5,204 men aged 45 to 80. At 12 months, PSA rose 0.15 ng/mL more on testosterone than on placebo, and the gap did not widen after that.
| Baseline PSA | Change at 12 months on testosterone | Change on placebo |
|---|---|---|
| Under 1.0 ng/mL | +0.19 ng/mL | +0.14 ng/mL |
| 1.0 to under 2.0 ng/mL | +0.26 ng/mL | −0.01 ng/mL |
| 2.0 to 3.0 ng/mL | +0.46 ng/mL | +0.01 ng/mL |
A review of 15 trials found the same average rise of 0.15 ng/mL. With shots into the muscle, the rise was larger, about 0.27 ng/mL. The AUA notes that the PSA response mainly depends on how low testosterone was before treatment.
Does TRT increase the risk of prostate cancer?
The best evidence so far shows no clear increase over a few years in men who were screened first. In TRAVERSE, high-grade prostate cancer occurred in 5 of 2,596 men (0.19%) on testosterone and 3 of 2,602 (0.12%) on placebo. Any prostate cancer occurred in 0.46% and 0.42%, and neither gap was statistically significant.
That trial had limits. It left out men with a PSA above 3.0 ng/mL and men judged at high risk of prostate cancer. Treatment lasted about 22 months on average, and only gel was used.
An earlier review found more prostate “events” overall on testosterone. These were mostly more biopsies and PSA rises, which may partly reflect more testing.
Two other lines of evidence are often quoted:
- Natural hormone levels. Pooled data from 18 studies found that men’s own testosterone levels were not linked to their later risk of prostate cancer.
- The saturation model. This theory says prostate tissue responds to rising testosterone only up to a fairly low level. Above that, more testosterone has little extra effect. It is a model that fits much of the data, not a proof.
The AUA asks clinicians to tell patients there is no evidence linking testosterone therapy to developing prostate cancer. Long-term data are still limited, which is why monitoring continues.
What else can raise PSA?
Several common things push PSA up, some only for a day or two:
- An enlarged prostate (benign prostatic hyperplasia), very common with age.
- Prostate infection or inflammation (prostatitis), or a urinary tract infection.
- A recent prostate biopsy or procedure, which can raise PSA for a month or two.
- Ejaculation. In a small study of 20 men, average PSA was still raised 24 hours afterwards.
- Long bike rides. PSA rose about 9.5% right after a long ride in men aged 50 to 71.
Some drugs push PSA down. Finasteride and dutasteride, used for hair loss or an enlarged prostate, lower PSA by about half. The finasteride label tells prescribers to double the value before comparing it with normal ranges.
Make sure whoever reads your PSA knows if you take either drug. TRAVERSE halved its referral triggers for men taking them, to a rise of 0.7 ng/mL or a PSA above 2.0 ng/mL.
What is a normal PSA by age?
There is no single normal value. The National Cancer Institute notes that a PSA above 4.0 ng/mL has long been treated as abnormal. Some doctors use lower cutoffs for younger men and higher ones for older men.
One older study of 471 healthy men in Minnesota proposed upper limits that rise with age: 2.5 ng/mL at 40 to 49, 3.5 at 50 to 59, 4.5 at 60 to 69 and 6.5 at 70 to 79. These figures are widely quoted but come from one community and one test. On TRT, the change from your own baseline matters more than any table.
How should you prepare for a PSA test?
- Avoid ejaculation and hard cycling for two days before the test, as the National Cancer Institute suggests. Keep the same routine every time.
- Tell your prescriber about a urinary infection, prostate symptoms or a recent procedure.
- Mention finasteride or dutasteride.
- Use the same lab where you can.
- Ask when to draw it. Your prescriber can say whether it goes with your usual draw for total T and hematocrit.
Which prostate symptoms should you report on TRT?
PSA is not the only prostate check. The Endocrine Society treats much worse urinary symptoms as a reason for a urology review on their own. Tell your prescriber if you notice:
- A weaker stream, straining, or a feeling that your bladder does not empty.
- Getting up to pass urine more often at night than before.
- Pain or burning when passing urine, or blood in your urine or semen.
In TRAVERSE, 20 men on testosterone and 16 on placebo had acute urinary retention. That means suddenly being unable to pass urine.
If you suddenly cannot pass urine at all, or have fever with pelvic pain, get urgent care the same day. Our guide to side effects of TRT covers the other warning signs.
What should you ask your prescriber about your PSA?
- What was my baseline PSA, and how far has it moved since?
- Does my age, ethnicity or family history change how you follow it?
- Should we repeat this result before deciding anything?
- At what change would you refer me to a urologist?
- How often will you check it after the first year?
How can you track your PSA on TRT?
The guideline triggers depend on your baseline. So the most useful thing to keep is a clean list, starting with the test before treatment. Note the date, value, lab and anything that might have nudged it.
TRTracker keeps every PSA with its range next to your other markers, so the change from baseline is easy to see. Our TRT blood work overview covers every test commonly checked on TRT.